Turning Point Therapeutics (TPTX) stock Forecast for 2022 – 2026
Last update: 05-16-2022, 12:32
Sector: HealthcareThe share price of Turning Point Therapeutics, Inc. (TPTX) now
What analysts predict:: $109.56
52-week high/low: $83.06 / $23.77
50/200 Day Moving Average: $29.01 / $45.89
This figure corresponds to the average price over the previous 50/200 days. For Turning Point Therapeutics stocks, the 50-day moving average is the support level today.
For Turning Point Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Turning Point Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Turning Point Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Turning Point Therapeutics share be worth in 2022 - 2026?
When should I take profit in Turning Point Therapeutics stock? When should I record a loss on Turning Point Therapeutics stock? What are analysts' forecasts for Turning Point Therapeutics stock? What is the future of Turning Point Therapeutics stock?
We forecast Turning Point Therapeutics stock performance using neural networks based on historical data on Turning Point Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Turning Point Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Turning Point Therapeutics shares. This happens once a day.
Historical and forecast chart of Turning Point Therapeutics stock
The chart below shows the historical price of Turning Point Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Turning Point Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Turning Point Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 18 | 31.45 | 30.81 | 32.27 | 4.72 |
| May 19 | 31.70 | 30.44 | 32.65 | 7.25 |
| May 20 | 31.36 | 30.38 | 31.98 | 5.26 |
| May 21 | 31.49 | 30.09 | 32.19 | 6.97 |
| May 22 | 30.83 | 30.16 | 31.44 | 4.23 |
| May 23 | 30.03 | 28.97 | 31.46 | 8.58 |
| May 24 | 30.63 | 29.60 | 31.82 | 7.51 |
| May 25 | 30.31 | 29.55 | 30.88 | 4.49 |
| May 26 | 29.37 | 28.84 | 30.37 | 5.32 |
| May 27 | 28.66 | 27.36 | 29.35 | 7.29 |
| May 28 | 27.60 | 27.10 | 28.46 | 5.01 |
| May 29 | 27.45 | 27.12 | 27.86 | 2.73 |
| May 30 | 29.05 | 28.37 | 30.18 | 6.39 |
| May 31 | 28.56 | 27.39 | 29.19 | 6.57 |
| Jun 01 | 28.75 | 27.88 | 29.66 | 6.37 |
| Jun 02 | 28.25 | 27.25 | 29.42 | 7.96 |
| Jun 03 | 27.94 | 27.47 | 28.66 | 4.33 |
| Jun 04 | 27.74 | 27.11 | 28.09 | 3.62 |
| Jun 05 | 26.54 | 25.60 | 27.12 | 5.91 |
| Jun 06 | 26.08 | 25.56 | 26.63 | 4.16 |
| Jun 07 | 26.38 | 26.03 | 27.52 | 5.72 |
| Jun 08 | 25.90 | 24.95 | 26.94 | 7.97 |
| Jun 09 | 26.03 | 25.23 | 26.89 | 6.56 |
| Jun 10 | 27.01 | 26.22 | 28.05 | 6.99 |
| Jun 11 | 26.72 | 25.56 | 27.89 | 9.09 |
| Jun 12 | 27.04 | 26.24 | 28.19 | 7.42 |
| Jun 13 | 25.87 | 25.05 | 26.60 | 6.20 |
| Jun 14 | 24.46 | 23.33 | 24.99 | 7.11 |
| Jun 15 | 24.28 | 23.73 | 24.97 | 5.22 |
| Jun 16 | 23.16 | 22.47 | 23.51 | 4.64 |
Turning Point Therapeutics Daily Price Targets
Turning Point Therapeutics Stock Forecast 05-18-2022.
Pessimistic target level: 30.81
Optimistic target level: 32.27
Turning Point Therapeutics Stock Forecast 05-19-2022.
Pessimistic target level: 30.44
Optimistic target level: 32.65
Turning Point Therapeutics Stock Forecast 05-20-2022.
Pessimistic target level: 30.38
Optimistic target level: 31.98
Turning Point Therapeutics Stock Forecast 05-21-2022.
Pessimistic target level: 30.09
Optimistic target level: 32.19
Turning Point Therapeutics Stock Forecast 05-22-2022.
Pessimistic target level: 30.16
Optimistic target level: 31.44
Turning Point Therapeutics Stock Forecast 05-23-2022.
Pessimistic target level: 28.97
Optimistic target level: 31.46
TPTX (TPTX) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 29.43 | 27.55 | 31.43 | 12.36 |
| Jul. | 28.84 | 26.31 | 32.91 | 20.06 |
| Aug. | 29.92 | 27.16 | 34.79 | 21.95 |
| Sep. | 23.74 | 20.65 | 27.49 | 24.88 |
| Oct. | 23.58 | 21.40 | 27.00 | 20.75 |
| Nov. | 24.93 | 21.53 | 26.90 | 19.98 |
| Dec. | 24.10 | 20.50 | 27.87 | 26.45 |
Turning Point Therapeutics forecast for this year
Turning Point Therapeutics Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $29.427. Pessimistic: $27.55. Optimistic: $31.43
Turning Point Therapeutics Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $28.8443. Pessimistic: $26.31. Optimistic: $32.91
Turning Point Therapeutics Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $29.9231. Pessimistic: $27.16. Optimistic: $34.79
Turning Point Therapeutics Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $23.735. Pessimistic: $20.65. Optimistic: $27.49
Turning Point Therapeutics Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $23.5784. Pessimistic: $21.40. Optimistic: $27.00
Turning Point Therapeutics Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $24.9271. Pessimistic: $21.53. Optimistic: $26.90
Turning Point Therapeutics Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $24.1045. Pessimistic: $20.50. Optimistic: $27.87
Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 23.42 | 22.28 | 25.84 | 13.76 |
| Feb | 22.90 | 19.42 | 25.62 | 24.19 |
| Mar | 19.98 | 18.97 | 22.26 | 14.81 |
| Apr | 19.49 | 16.36 | 21.81 | 24.97 |
| May | 16.28 | 14.31 | 17.60 | 18.72 |
| Jun | 16.06 | 13.41 | 17.90 | 25.07 |
| Jul | 19.53 | 17.51 | 22.58 | 22.45 |
| Aug | 21.85 | 18.43 | 24.20 | 23.83 |
| Sep | 21.65 | 17.84 | 22.75 | 21.57 |
| Oct | 25.51 | 23.94 | 28.04 | 14.61 |
| Nov | 24.78 | 20.58 | 28.16 | 26.91 |
| Dec | 24.51 | 20.57 | 26.67 | 22.85 |
Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 20.90 | 17.63 | 22.64 | 22.13 |
| Feb | 19.20 | 16.28 | 21.98 | 25.93 |
| Mar | 18.52 | 15.26 | 21.78 | 29.93 |
| Apr | 14.61 | 13.42 | 16.96 | 20.85 |
| May | 15.54 | 13.73 | 16.98 | 19.13 |
| Jun | 18.14 | 15.82 | 19.82 | 20.14 |
| Jul | 18.22 | 15.01 | 20.70 | 27.49 |
| Aug | 19.86 | 18.68 | 21.52 | 13.20 |
| Sep | 20.91 | 18.43 | 23.26 | 20.77 |
| Oct | 17.74 | 15.63 | 18.91 | 17.34 |
| Nov | 17.11 | 15.27 | 19.26 | 20.72 |
| Dec | 16.51 | 13.75 | 18.07 | 23.92 |
Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 19.96 | 17.24 | 21.37 | 19.32 |
| Feb | 20.09 | 18.81 | 22.83 | 17.62 |
| Mar | 18.77 | 17.94 | 21.29 | 15.71 |
| Apr | 19.63 | 16.78 | 23.05 | 27.18 |
| May | 19.29 | 16.87 | 20.35 | 17.10 |
| Jun | 18.91 | 16.49 | 20.53 | 19.65 |
| Jul | 19.49 | 17.17 | 21.46 | 19.98 |
| Aug | 18.46 | 16.06 | 20.53 | 21.76 |
| Sep | 18.01 | 15.56 | 20.63 | 24.59 |
| Oct | 19.76 | 17.37 | 22.54 | 22.95 |
| Nov | 17.89 | 17.02 | 21.00 | 18.93 |
| Dec | 16.86 | 15.31 | 18.90 | 19.04 |
Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 15.83 | 14.68 | 18.61 | 21.14 |
| Feb | 14.29 | 13.60 | 16.12 | 15.61 |
| Mar | 14.07 | 12.84 | 14.94 | 14.09 |
| Apr | 16.67 | 15.50 | 18.88 | 17.88 |
| May | 15.28 | 13.06 | 17.94 | 27.18 |
| Jun | 18.20 | 16.64 | 20.13 | 17.31 |
| Jul | 18.00 | 16.86 | 20.98 | 19.64 |
| Aug | 16.94 | 14.92 | 18.72 | 20.30 |
| Sep | 17.20 | 15.91 | 19.62 | 18.90 |
| Oct | 15.95 | 13.88 | 17.60 | 21.13 |
| Nov | 14.90 | 14.21 | 17.39 | 18.28 |
| Dec | 15.48 | 13.00 | 16.23 | 19.93 |
Turning Point Therapeutics information and performance
Turning Point Therapeutics, Inc., a clinical stage biopharmaceutical company, designs and develops new small molecule targeted cancer therapies. He is developing a suite of tyrosine kinase inhibitors (TKIs) that targets cancer genetic factors in previously TKI-naive and TKI-treated patients.
Turning Point Therapeutics Address
10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, US
Market Capitalization: 1 331 055 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -46 895 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -4.802
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.982
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 11.52
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 49666300
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A